Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVT: Ethyl ester versus triglyceride omega-3 in moderate hypertriglyceridemia
2012-003029-11Phase 4Completed
- Sponsor
- Steen Stender
- Start
- Sep 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of eicosapentaenoic acid + docosahexaenoic acid in hypertriglyceridemia and combined dyslipidaemia (3 arms), sponsored by Steen Stender. Primary endpoint: Change in non-fasting plasma triglycerides versus placebo. Started Sep 2012; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
hypertriglyceridemiacombined dyslipidaemia
Beyond the preview
Go deeper on 2012-003029-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003029-11.